Opioid/Substance Use Disorders CE: The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020 show details
On December 29, 2022, the Consolidated Appropriations Act of 2023 enacted a new one-time, eight-hour training requirement for all Drug Enforcement Administration (DEA)-registered practitioners on the treatment and management of patients with opioid or other substance use disorders. This journal-based activity will help DEA registered practitioners at MH to meet this requirement.
